Slingerlands, NY, United States of America

Sally Temple

This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Regenerative Research Foundation, Albany Medical College. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sally Temple. Retrieved from https://idiyas.com/inventor/sally-temple

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 5)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Slingerlands, NY (US) (2011 - 2018)
Rensselaer, NY (US) (2021 - 2023)

Company Filing History:

4 out of 9

Regenerative Research Foundation

patents

1 out of 71

Albany Medical College

patents

Years Active: 2011-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827683 - Bi-functional anti-tau polypeptides and use thereof (2023-11-28),

2. 11072639 - Bi-functional anti-tau polypeptides and use thereof (2021-07-27),

3. 10034916 - Methods of treating a retinal disease by retinal pigment epithelial stem cells (2018-07-31),

4. 8481313 - Retinal pigment epithelial stem cells (2013-07-09),

5. 7901936 - Method for stimulating self-renewal of neural stem cells and enhancing neurogenesis (2011-03-08),

Title: The Innovative Contributions of Sally Temple

Introduction

Sally Temple is a prominent inventor based in Slingerlands, NY (US), known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable strides in the development of therapeutic solutions for neurodegenerative diseases.

Latest Patents

Among her latest patents are the bi-functional anti-tau polypeptides, which are designed to target tauopathies. These multifunctional polypeptides consist of a first domain that includes an anti-tau antigen binding domain and a second domain featuring a proteasome-targeting PEST motif. The innovative methods for utilizing these polypeptides in the treatment of tauopathies highlight her commitment to advancing medical science.

Career Highlights

Sally Temple has worked with notable organizations such as the Regenerative Research Foundation and Albany Medical College. Her work in these institutions has allowed her to collaborate with leading experts in the field, further enhancing her research and development efforts.

Collaborations

Some of her notable coworkers include Anne Messer and David Butler, who have contributed to her projects and research initiatives.

Conclusion

Sally Temple's innovative work and dedication to addressing complex medical challenges through her patents exemplify her role as a leading inventor in biotechnology. Her contributions continue to pave the way for advancements in the treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.